share_log

How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way

How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way

技術如何改變心理健康治療的遊戲規則,而人工智能正在引領潮流
newsfile ·  2023/11/22 20:00

Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - November 22, 2023) - Investorideas.com (www.investorideas.com), a global investor news source covering health and wellness stocks releases a special report on breakthrough technologies for mental health, featuring PanGenomic Health Inc. (CSE: NARA) (AQSE: NARA). PanGenomic describes itself as 'Your smart tech partner in natural health' and is using the power of AI to help revolutionize healing.

溫哥華、基洛納和不列顛哥倫比亞省三角洲--(Newsfile Corp.,2023 年 11 月 22 日)-Investorideas.com (萬維網。Investorideas.com),一家報道健康和保健股票的全球投資者新聞來源發佈了一份關於心理健康突破性技術的特別報告,該報告由PangeNomic Health Inc.(CSE:NARA)(澳大利亞證券交易所股票代碼:NARA)報道。PangeNomic 將自己描述爲 '您在自然健康領域的智能技術合作夥伴' 並正在利用人工智能的力量來幫助徹底改變治療方式。

Read the full article on Investorideas

閱讀有關 Investorideas 的完整文章

The global mental wellness market is anticipated to grow from USD 145.83 billion to USD 280.52 billion in 10 years. The market will experience rapid growth due to the rising awareness about mental wellness, major market players are investing extensive capital in developing therapies, drugs, medical devices, equipment, systems, and treatments based on research findings to cater to the growing mental wellness market.

預計全球心理健康市場將在10年內從1458.3億美元增長到2805.2億美元。由於人們對心理健康的認識不斷提高,市場將實現快速增長,主要市場參與者正在根據研究結果投資大量資本開發療法、藥物、醫療器械、設備、系統和治療方法,以滿足不斷增長的心理健康市場。

Most medical experts agree we are in a global mental health crisis and it is only worsening. While some companies turn to traditional methods including pharmaceuticals to solve the growing problem, others are looking to revolutionize the way we treat mental health using technology, and AI is aiming to take the driver's seat.

大多數醫學專家都認爲,我們正處於全球心理健康危機之中,而且這種危機只會惡化。儘管一些公司轉向包括藥品在內的傳統方法來解決日益嚴重的問題,但另一些公司則希望通過技術徹底改變我們治療心理健康的方式,而人工智能的目標是佔據主導地位。

PanGenomic Health Inc. (CSE: NARA) (AQSE: NARA), a precision health company that has developed a self-care digital platform using AI recently announced that its subsidiary, MUJN Diagnostics Inc. has launched its BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service.

使用人工智能開發自我保健數字平台的精準健康公司PangeNomic Health Inc.(CSE:NARA)最近宣佈,其子公司MUJN Diagnostics Inc. 已推出其BDNF(腦源性神經營養因子)心理健康生物標誌物健康評估服務。

More significantly, it has completed its first sale of the point-of-care test marketed to health clinics in Canada.

更重要的是,它已經完成了向加拿大健康診所銷售的即時測試的首次銷售。

From the news: MUJN Diagnostics Inc. is a wholly-owned subsidiary of PanGenomic Health Inc. and is focused on developing a decision support system for alternative healthcare providers. MUJN's Decision Support System is intended to include biomarker diagnostics, symptom and treatment tracking, and personalized health analytics, with the goal of empowering healthcare providers and their patients towards better outcomes.

來自新聞: MUJN Diagnostics Inc. 是PangeNomic Health Inc.的全資子公司,專注於爲替代醫療保健提供者開發決策支持系統。MUJN的決策支持系統旨在包括生物標誌物診斷、症狀和治療跟蹤以及個性化健康分析,目的是使醫療保健提供者及其患者獲得更好的療效。

"Our strategy is to continue to expand MUJN Diagnostic's health services beyond our initial Vitamin D assessments to include rapid in-clinic access to a panel of mental health patient point-of-care biomarker assessments," said Vincent Lum, CEO of MUJN Diagnostics and Co-Founder of PanGenomic Health. "Our newest product is the MUJN BDNF Biomarker assessment for mental health and wellness. Changes in BDNF levels provide important information for health practitioners when considering treatment options for patients with brain health concerns such as major depressive disorder."

MUJN Diagnostics首席執行官兼PangeNomic Health聯合創始人Vincent Lum表示:“我們的戰略是繼續將MUJN Diagnostics的健康服務擴展到最初的維生素D評估之外,包括在臨床中快速獲得心理健康患者即時生物標誌物評估小組。”“我們的最新產品是MUJN BDNF心理健康和保健生物標誌物評估。BDNF水平的變化爲醫療從業人員考慮有大腦健康問題(例如重度抑鬱症)的治療方案提供了重要信息。”

From the news: Current clinical research on BDNF has found that:

來自新聞: 目前對BDNF的臨床研究發現:

BDNF plays a significant role in the survival and development as well as creation of new neurons. BDNF has been shown to be a critical regulator of neurocognitive functions and impairment of BDNF levels have been connected to a variety of mental health diseases.

BDNF 在新神經元的生存、發育和創造中起着重要作用。BDNF已被證明是神經認知功能的關鍵調節劑,BDNF水平的損害與各種心理健康疾病有關。

Decrease in the expression of BDNF is seen in many neurological problems such as Depression, Alzheimer's, Parkinson's, Huntington's and bipolar disease.

在抑鬱症、阿爾茨海默氏症、帕金森氏症、亨廷頓氏症和躁鬱症等許多神經系統問題中,BDNF的表達會降低。

BDNF serum levels are lower in patients with major depressive disorder compared with those in healthy controls. Pharmacological treatments often lead to an increase in BDNF levels, which correlates with an improvement in a patient's mental health condition.

與健康對照組相比,重度抑鬱症患者的血清 BDNF 水平較低。藥物治療通常會導致BDNF水平升高,這與患者心理健康狀況的改善相關。

PanGenomic's current product line includes its Nustasis AI Platform, MUJN Diagnostics, and the NARA and MindLeap consumer apps, all designed to complement conventional medicine, and simplify the path to better health.

PangeNomic目前的產品線包括其Nustasis人工智能平台、MUJN Diagnostics以及NARA和MindLeap消費者應用程序,所有這些應用程序都旨在補充傳統醫學,簡化通往更健康的道路。

According to a June press release; "The Company is planning to launch Conversational AI on the web based NARA platform by Q3, followed by a roll out on the NARA app by Q4 of this year."

根據6月份的新聞稿;“該公司計劃在第三季度之前在基於網絡的NARA平台上推出對話式人工智能,然後在今年第四季度之前在NARA應用程序上推出。”

A new entry to the public market with an AI approach to mental health, WaveDancer, Inc. announced last week that it has entered into a definitive merger agreement with privately held, commercial-stage, medical technology company, Firefly Neuroscience, Inc. ("Firefly"), to combine the companies in an all-stock transaction. The combined company will focus on continuing to develop and commercialize Firefly's Artificial Intelligence driven Brain Network Analytics (BNA) platform, which was previously cleared by the U.S. Food and Drug Administration ("FDA"). Upon closing, which is currently expected in Q1-2024, the combined company is expected to operate under the name Firefly Neuroscience, Inc., and trade on the Nasdaq Capital Market.

WaveDancer, Inc. 以人工智能方法進入公共市場,上週宣佈,它已與私營的、處於商業階段的醫療技術公司Firefly Neuroscience, Inc.(“Firefly”)簽訂了最終合併協議,將兩家公司合併成全股交易。合併後的公司將專注於繼續開發和商業化Firefly的人工智能驅動的大腦網絡分析(BNA)平台,該平台此前已獲得美國食品藥品監督管理局(“FDA”)的批准。預計合併後的公司將在Firefly Neuroscience, Inc. 的名義下運營,並在納斯達克資本市場上市,目前預計將在 Q1-2024 上市。

Describing Firefly's Brain Network Analytics (BNA) platform the news says, "BNA is an FDA-cleared, cloud-based, AI-powered platform used to objectively assess brain function by comparing patient electroencephalograms (EEGs) with a proprietary database of standardized, high-definition EEGs and behavioral data. BNA is used by psychiatrists and neurologists in the United States to support the diagnosis of mental illnesses and cognitive disorders; optimize treatment care pathways; and improve patient compliance to therapy. Real-world clinical use has shown that when BNA is used as part of patient management, patients showed improved response rates; enhanced therapy compliance; and reduced non-responder rates and need for medication switching."

該新聞在描述Firefly的大腦網絡分析(BNA)平台時說:“BNA是一個經美國食品藥品管理局批准的、基於雲的、基於人工智能的平台,用於通過將患者腦電圖(EEG)與標準化、高清腦電圖和行爲數據的專有數據庫進行比較來客觀地評估大腦功能。美國的精神科醫生和神經科醫生使用BNA來支持精神疾病和認知障礙的診斷;優化治療護理途徑;提高患者對治療的依從性。現實世界的臨床應用表明,當使用BNA作爲患者管理的一部分時,患者的反應率有所提高;治療依從性得到提高;無反應率和藥物轉換需求降低。”

From the news: Jamie Benoit, Chief Executive Officer and Chairman of WaveDancer, commented, "Following a strategic review and analysis of our long-term prospects as a publicly-traded company, the Board determined that this merger is in the best interests of WaveDancer's stockholders and an attractive opportunity to realize significant value as Firefly pursues multiple market opportunities for its BNA platform. Firefly has emerged from the rigorous FDA approval process and its BNA platform has been subjected to comprehensive academic peer-review. We believe these factors contribute to a competitive advantage for Firefly and position it as a unique public company."

來自新聞: WaveDancer首席執行官兼董事長傑米·貝努伊特評論說:“在對我們作爲上市公司的長期前景進行了戰略審查和分析後,董事會確定,此次合併符合WaveDancer股東的最大利益,也是實現巨大價值的絕佳機會,因爲Firefly正在爲其BNA平台尋求多個市場機會。Firefly已經擺脫了嚴格的FDA批准程序,其BNA平台已經過全面的學術同行評審。我們相信這些因素有助於Firefly獲得競爭優勢,並將其定位爲一家獨特的上市公司。”

Harnessing the power of AI for mental health improvement, Virtual care provider Amwell as reported by Behavioral Health "has its sights set on using artificial intelligence to bolster its behavioral health capabilities."

據行爲健康報道,虛擬護理提供商Amwell利用人工智能的力量改善心理健康“其目標是使用人工智能來增強其行爲健康能力。”

"The telehealth giant recently launched a system within its platform that immediately connects patients to a therapist in real time."

“這家遠程醫療巨頭最近在其平台內啓動了一個系統,可以立即將患者與治療師實時連接起來。”

"After Amwell providers or its AI-backed automated systems determine the patient needs mental health services, the patient is queued to see a clinician on the same platform. The move is meant to bridge a systemic gap in health care: patient activation."

“在Amwell提供商或其人工智能支持的自動化系統確定患者需要心理健康服務後,患者將排隊等候在同一平台上看臨床醫生。此舉旨在彌合醫療保健領域的系統性差距:激活患者。”

"Amwell rolled out the system near the beginning of the quarter. It's part of the company's rolling implementation of Converge, a unified tech platform."

“Amwell在本季度初推出了該系統。這是該公司滾動實施統一技術平台Converge的一部分。”

"Survey data show that about 42% of Americans who sought mental health care couldn't get it because of costs or other barriers, such as lack of proximity to care. This is a dire roadblock that keeps patients from getting the care they seek, or that is prescribed to them by primary care providers, who already have access to the patient."

“調查數據顯示,在尋求心理健康護理的美國人中,約有42%由於成本或其他障礙(例如缺乏醫療服務)而無法獲得心理保健。這是一個嚴重的障礙,使患者無法獲得他們所尋求的護理,也無法獲得已經可以接觸到患者的初級保健提供者爲他們開的處方。”

Also using technology for mental health, Talkspace, a leading virtual behavioral healthcare company recently reported third quarter 2023 financial results.

領先的虛擬行爲醫療保健公司Talkspace也將技術用於心理健康,最近公佈了2023年第三季度的財務業績。

Third Quarter 2023 Key Performance Metrics:

2023 年第三季度關鍵績效指標:

Revenue increased 32% over the prior-year period to $38.6 million, driven by a 79% year-over-year increase in the B2B revenue categories, partially offset by a 32% year-over-year consumer revenue decline.

收入同比增長32%,達到3,860萬美元,這得益於B2B收入類別同比增長79%,但部分被32%的消費者收入同比下降所抵消。

Gross profit increased 29% over the prior-year period to $18.8 million, and gross margin declined to 48.8% from 49.8% year-over-year, driven by a shift in revenue mix towards payor.

在收入結構向付款人的轉變的推動下,毛利率同比增長29%至1,880萬美元,毛利率從49.8%下降至48.8%。

Operating expenses were $24.0 million, down 30% year-over-year, driven by a reduction across all of our operating cost categories.

運營支出爲2400萬美元,同比下降30%,這得益於我們所有運營成本類別的減少。

Net loss was $(4.4) million, an improvement from $(18.0) million net loss in the third quarter of 2022, primarily driven by lower operating expenses and an increase in revenues.

淨虧損爲440萬美元,較2022年第三季度(1,800萬美元)的淨虧損有所改善,這主要是受運營費用減少和收入增加的推動。

Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services from self-guided products to individual and couples therapy, in addition to psychiatric treatment and medication management. With Talkspace's core psychotherapy offering, members are matched with one of thousands of licensed providers across all 50 states and can choose from a variety of subscription plans including live video, text or audio chat sessions and/or asynchronous text messaging.

Talkspace開創了從任何地方向持牌治療師發短信的功能,現在除了精神病治療和藥物管理外,還提供從自助產品到個人和夫妻療法的全套心理健康服務。藉助Talkspace的核心心理治療產品,會員可以與所有50個州的數千家持牌提供者中的一家進行匹配,並且可以從各種訂閱計劃中進行選擇,包括實時視頻、短信或音頻聊天會話和/或異步短信。

As technology evolves, the applications for health and wellness are endless. As PanGenomic Health says – AI and other technology may become natural health's 'smart tech partner' of the future.

隨着技術的發展,健康和保健的應用無窮無盡。正如PangeNomic Health所說,人工智能和其他技術可能會成爲自然健康未來的 “智能技術合作夥伴”。

About Investorideas.com - Big Investing Ideas
Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea's original branded content includes the Crypto Corner Podcast, Play by Play Sports Podcast, Cannabis News and Stocks on the Move Podcast, Cleantech and Climate Change Podcast, Exploring Mining Podcast, Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

關於 Investorideas.com-大型投資創意
Investorideas.com是一個提供投資理念的平台。我們發佈重大股票新聞、股票研究、訪客帖子,並製作收視率最高的原創投資播客,以及以新興公司和行業領導者爲主題的行業標籤文章。Investor Idea的原創品牌內容包括Crypto Corner播客、Play by Play體育播客、大麻新聞和股票走勢播客、清潔技術和氣候變化播客、探索礦業播客、博彩股票播客和AI Eye播客。我們還爲人工智能和科技、生物技術、大麻、清潔技術、加密貨幣、國防、遊戲、健康和保健、採礦、石油和天然氣、體育和水資源創建免費的投資者股票名錄。

Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors.

我們所涵蓋領域的上市公司可以使用我們的新聞發佈和內容創作服務來幫助向感興趣的投資者講述他們的故事。

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: This tag article featuring NARA is paid for content ( third party) Learn more about the cost of ticker tag articles and our other news services on the Investorideas.com newswire More disclaimer info:
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

免責聲明/披露: Investorideas.com是一家數字出版商,出版第三方來源的新聞、文章和股票研究,並創作原創內容,包括視頻、訪談和文章。investorideas 創作的原創內容受版權法的保護,但聯合發行權除外。我們的網站不建議購買或出售股票、服務或產品。我們網站上的任何內容都不應被解釋爲購買或出售產品或證券的要約或邀請。所有投資都涉及風險和可能的損失。該網站目前在新聞出版和發行、社交媒體和營銷、內容創作等方面獲得報酬。每份補償新聞稿都會發布披露,必要時發佈/創建的內容,但除此之外,新聞沒有得到補償,發佈的完全是爲了讀者和關注者的利益。就具體問題直接聯繫每家公司的管理層和投資者關係。披露:這篇以 NARA 爲主題的標籤文章是按內容付費的(第三方)在 Investorideas.com 新聞專線上了解有關股票標籤文章和我們其他新聞服務的費用更多免責聲明信息:
全球投資者必須遵守每個國家的法規。請閱讀 Investorideas.com 隱私政策:

Follow us on Twitter
Follow us on Facebook
Follow us on YouTube

在推特上關注我們
在臉書上關注我們
在 YouTube 上關注我們

Contact Investorideas.com
800-665-0411

聯繫 Investorideas.com
800-665-0411

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論